YNR040W Antibody

What is YNR040W and why is it significant in mitochondrial research?

YNR040W is an uncharacterized protein found in Saccharomyces cerevisiae (baker's yeast) that has been identified as a critical component of mitochondrial function. Research indicates that YNR040W is a cis Puf3p target in mitochondrial biogenesis pathways, suggesting its importance in mitochondrial development and function . Previous large-scale screening studies have consistently detected this protein in mitochondria, confirming its mitochondrial localization . The significance of YNR040W extends to its potential role as a critical subunit of the mitoribosomal interactome, which is essential for protein synthesis within mitochondria . This makes YNR040W antibodies valuable tools for researchers studying mitochondrial biogenesis, function, and related disease states.

What are the key specifications of commercially available YNR040W antibodies?

The YNR040W antibody available for research has several important specifications that researchers should consider when planning experiments:

• Antibody Type: Polyclonal antibody raised in rabbit

• Target Species: Specifically targets Saccharomyces cerevisiae (strain ATCC 204508 / S288c)

• Immunogen: Recombinant Saccharomyces cerevisiae YNR040W protein

• Purification Method: Antigen affinity purified

• Validated Applications: ELISA and Western blot (WB)

• Storage Conditions: Recommended storage at -20°C or -80°C to avoid repeated freeze-thaw cycles

• Storage Buffer: Preserved in 0.03% Proclin 300, 50% Glycerol, 0.01M PBS at pH 7.4

• Form: Liquid

• Research Use Only: Not approved for diagnostic or therapeutic procedures

How should researchers optimize Western blot protocols for YNR040W detection?

For optimal Western blot results when detecting YNR040W:

• Sample Preparation:

  • Extract mitochondrial proteins using gentle lysis buffers containing protease inhibitors to preserve protein integrity

  • For yeast samples, glass bead lysis or enzymatic methods with zymolyase followed by differential centrifugation yield good mitochondrial fractions

• Protein Separation:

  • Use 10-12% SDS-PAGE gels for optimal resolution of YNR040W

  • Load 20-40 μg of total protein per lane, or 5-10 μg of enriched mitochondrial fraction

• Transfer and Blocking:

  • PVDF membranes often provide better results than nitrocellulose for mitochondrial proteins

  • Block with 5% non-fat milk in TBST for 1 hour at room temperature

• Antibody Incubation:

  • Dilute primary YNR040W antibody 1:500 to 1:1000 in blocking buffer

  • Incubate overnight at 4°C with gentle rocking

  • Wash thoroughly with TBST (4 washes, 5 minutes each)

  • Use HRP-conjugated anti-rabbit secondary antibody at 1:5000 dilution

• Detection:

  • Enhanced chemiluminescence (ECL) detection typically provides sufficient sensitivity

  • For weak signals, consider using signal enhancers or longer exposure times

• Controls:

  • Include a positive control from wild-type yeast mitochondrial extract

  • Include a negative control using an unrelated antibody of the same isotype

This protocol may require optimization based on specific laboratory conditions and equipment.

How can YNR040W antibody be used to study mitochondrial biogenesis pathways?

YNR040W antibody serves as a valuable tool for investigating mitochondrial biogenesis pathways through several methodological approaches:

These techniques allow researchers to place YNR040W in the broader context of mitochondrial biogenesis pathways and understand its functional significance.

What are the recommended procedures for immunoprecipitation using YNR040W antibody?

For effective immunoprecipitation of YNR040W and associated proteins:

• Cell/Tissue Preparation:

  • Harvest yeast cells in mid-log phase for optimal protein expression

  • Prepare mitochondrial extracts using gentle lysis conditions to preserve protein-protein interactions

  • Use a lysis buffer containing 150 mM NaCl, 50 mM Tris-HCl (pH 7.5), 1% NP-40, 0.5% sodium deoxycholate, and protease inhibitor cocktail

• Pre-clearing:

  • Pre-clear lysate with Protein A/G beads for 1 hour at 4°C to reduce non-specific binding

  • Remove beads by centrifugation before adding antibody

• Antibody Binding:

  • Add 2-5 μg of YNR040W antibody per 500 μg of total protein

  • Incubate overnight at 4°C with gentle rotation

  • Include a control sample with non-specific IgG from the same species

• Immunoprecipitation:

  • Add pre-washed Protein A/G beads to capture antibody-protein complexes

  • Incubate for 2-3 hours at 4°C

  • Wash beads 4-5 times with cold lysis buffer

  • Consider including a final stringent wash to reduce background

• Elution and Analysis:

  • Elute bound proteins with SDS sample buffer at 95°C for 5 minutes

  • Analyze by SDS-PAGE followed by Western blotting or mass spectrometry

  • For protein complex identification, consider on-bead digestion followed by LC-MS/MS

• Validation:

  • Confirm successful immunoprecipitation by Western blot using a portion of the eluted material

  • Use reverse co-immunoprecipitation with antibodies against suspected interaction partners

This protocol should be optimized based on specific experimental needs and the abundance of YNR040W in your system.

How can researchers troubleshoot common issues with YNR040W antibody in experimental applications?

When addressing these issues, it's advisable to first test modifications individually and keep detailed records of optimization steps for reproducibility.

How can YNR040W antibody be utilized in studying mitoribosomal function across species?

YNR040W has been identified as a critical subunit of the mitoribosomal interactome , making its antibody valuable for comparative studies across species:

• Cross-species Reactivity Analysis:

  • Though the commercially available antibody specifically targets S. cerevisiae YNR040W , researchers can assess potential cross-reactivity with homologous proteins in related species

  • Begin with closely related yeast species and expand to more distant eukaryotes based on sequence homology

  • Use bioinformatics tools to identify conserved epitopes that might be recognized by the antibody

• Evolutionary Conservation Studies:

  • Combine antibody-based detection with genetic complementation assays

  • Develop epitope tagging strategies for homologous proteins in other species when direct detection isn't possible

  • Create a comprehensive phylogenetic profile of functional conservation across evolutionary time

• Mitoribosomal Assembly Comparison:

  • Use the antibody in conjunction with density gradient centrifugation to isolate mitoribosomes at different assembly stages

  • Compare assembly intermediates between species to identify conserved and divergent assembly pathways

  • Combine with cryo-EM studies to correlate structural features with functional domains

• Pathogenic Relevance:

  • Investigate potential homologs in pathogenic organisms (such as Plasmodium) where mitoribosomal function is critical

  • Develop experimental systems to test functional conservation in disease-relevant contexts

  • Use YNR040W antibody-derived data to inform drug development targeting pathogen-specific mitoribosomal features

• Methodological Considerations:

  • For cross-species studies, validate antibody specificity through Western blot analysis of recombinant proteins

  • Consider developing a panel of monoclonal antibodies targeting different epitopes for improved cross-species applications

  • Implement quantitative mass spectrometry approaches as complementary validation when antibody cross-reactivity is limited

These approaches allow researchers to leverage YNR040W antibody beyond its primary target organism and contribute to broader understanding of mitoribosomal evolution.

What are the considerations for using YNR040W antibody in studying mitochondrial dysfunction in disease models?

When applying YNR040W antibody research to disease models:

• Selecting Appropriate Model Systems:

  • Consider yeast as a model organism for mitochondrial diseases given the conservation of core mitochondrial functions

  • Establish whether the human homolog of YNR040W (if identified) plays a similar role in mitoribosomal function

  • Develop humanized yeast models expressing the human homolog to bridge cross-species research

• Disease-relevant Experimental Design:

  • Study YNR040W expression and localization under conditions that mimic disease states:

    • Oxidative stress (H₂O₂ treatment)

    • Respiratory chain inhibition (using specific complex inhibitors)

    • mtDNA depletion models

  • Compare YNR040W protein levels between wild-type and disease model conditions using quantitative Western blot

• Integrated Multi-omics Approach:

  • Combine antibody-based protein detection with:

    • Transcriptomics to assess expression changes

    • Metabolomics to identify downstream metabolic effects

    • Proteomics to capture changes in the broader mitochondrial proteome

  • Use YNR040W antibody for immunoprecipitation followed by mass spectrometry to identify altered protein interactions in disease states

• Technical Considerations:

  • Optimize fixation and permeabilization protocols for diseased tissues where mitochondrial morphology may be altered

  • Consider super-resolution microscopy techniques to detect subtle changes in YNR040W localization

  • Implement proximity labeling approaches (BioID, APEX) in conjunction with antibody validation to map the changing interactome in disease contexts

• Translational Research Applications:

  • Use YNR040W antibody data from model systems to identify potential biomarkers for mitochondrial dysfunction

  • Screen compound libraries for molecules that restore normal YNR040W function or expression

  • Develop assays to monitor mitoribosomal integrity as a measure of therapeutic effectiveness

These approaches enable researchers to leverage YNR040W antibody for deeper insights into mitochondrial dysfunction mechanisms in disease models.

How can researchers integrate YNR040W antibody data with other mitochondrial biogenesis markers for comprehensive pathway analysis?

To develop a comprehensive understanding of mitochondrial biogenesis pathways:

• Temporal Profiling of Biogenesis Markers:

  • Design time-course experiments that track multiple markers including:

    • YNR040W for mitoribosomal assembly

    • Tom70p and Hsp60p (known Puf3p targets)

    • Citrate synthase (Cit1p) for TCA cycle integration

    • Respiratory chain complex components

  • Use antibody arrays or multiplexed Western blotting to simultaneously quantify these proteins

  • Correlate protein expression patterns to identify coordinated regulation mechanisms

• Spatial Organization Analysis:

  • Implement multi-color immunofluorescence microscopy with YNR040W antibody and other marker antibodies

  • Quantify co-localization coefficients to determine spatial relationships during biogenesis

  • Use structured illumination or STED microscopy to resolve submitochondrial localization

  • Correlate with electron microscopy data for ultrastructural context

• Functional Interaction Mapping:

  • Combine YNR040W antibody immunoprecipitation with sequential immunoprecipitation of other biogenesis factors

  • Implement BioID or APEX proximity labeling with YNR040W as bait

  • Develop a hierarchical interaction map based on temporal appearance of interactions

  • Quantify interaction strength changes during different biogenesis stages

• Integrative Data Analysis:

  • Create a multivariate statistical model incorporating:

    • Protein expression data from antibody-based assays

    • Transcriptomic data for coordinated expression analysis

    • Metabolomic data to link functional outputs

    • Known regulatory information (e.g., Puf3p binding sites)

  • Implement machine learning approaches to identify novel regulatory nodes

• Visualization and Analysis Methods:

  Analysis Type	Methods	Data Integration Approach
  Network Visualization	Cytoscape with clusterMaker	Integrate protein-protein interaction data with expression correlations
  Pathway Enrichment	GSEA, Metascape	Map YNR040W-associated proteins to known pathways
  Temporal Dynamics	Principal Component Analysis	Reduce dimensionality of time-course data to identify key transitions
  Causal Modeling	Bayesian Networks	Infer directional relationships between pathway components
  Regulatory Analysis	Motif Enrichment	Identify common regulatory elements in co-expressed genes

By integrating these approaches, researchers can place YNR040W in the context of broader mitochondrial biogenesis pathways and identify key regulatory relationships.

What methodologies are recommended for studying the role of YNR040W in the Puf3p post-transcriptional regulatory network?

YNR040W has been identified as a cis Puf3p target involved in mitochondrial biogenesis , suggesting it is subject to post-transcriptional regulation. To investigate this relationship:

• RNA-Protein Interaction Studies:

  • Implement RNA immunoprecipitation (RIP) using antibodies against Puf3p to confirm direct binding to YNR040W mRNA

  • Perform electrophoretic mobility shift assays (EMSAs) with purified Puf3p and labeled YNR040W mRNA fragments

  • Use crosslinking and immunoprecipitation (CLIP) methods to map precise binding sites at nucleotide resolution

  • Validate findings with reporter constructs containing wild-type or mutated Puf3p binding sites

• Translation Regulation Analysis:

  • Develop polysome profiling experiments comparing YNR040W mRNA distribution in wild-type versus Δpuf3 strains

  • Use ribosome profiling to assess translation efficiency changes

  • Implement nascent chain tracking with antibodies against YNR040W to measure translation rates in real-time

  • Correlate translation rates with Puf3p activity under different metabolic conditions

• Coordinated Regulation Studies:

  • Compare expression patterns of YNR040W with other known Puf3p targets including Tom70p and Hsp60p

  • Investigate whether the significant increase in citrate levels observed in Δpuf3 yeast correlates with YNR040W expression

  • Develop comprehensive models of the Puf3p regulon including YNR040W and related mitochondrial proteins

  • Assess whether YNR040W shares regulatory patterns with the uncharacterized proteins Rdl2p, Mpm1p, and Fmp10p, which are also cis Puf3p targets

• Subcellular Localization Dynamics:

  • Use YNR040W antibody to track protein localization changes in response to Puf3p modulation

  • Implement live-cell imaging with fluorescently tagged YNR040W to observe dynamic localization patterns

  • Correlate localization patterns with mitochondrial function metrics

These methodologies provide a comprehensive approach to understanding YNR040W's role within the Puf3p regulatory network and its functional consequences for mitochondrial biogenesis.

How can researchers design effective knockdown/knockout experiments to study YNR040W function using the antibody for validation?

Designing rigorous genetic manipulation studies with proper antibody validation:

• Knockout Strategy Design:

  • Implement CRISPR-Cas9 gene editing for precise YNR040W deletion in S. cerevisiae

  • Consider conditional knockout systems if complete deletion proves lethal

  • Design knockouts with minimal disruption to surrounding genomic regions

  • Include appropriate selection markers for efficient screening

• RNAi/Knockdown Approaches:

  • Design inducible shRNA or siRNA constructs targeting different regions of YNR040W mRNA

  • Consider tetracycline-regulated expression systems for temporal control

  • Implement a knockdown approach similar to the TetR-DOZI-aptamer system used for mitoribosomal proteins in Plasmodium

  • Test multiple constructs to identify those with optimal knockdown efficiency

• Antibody-based Validation Protocols:

  • Perform quantitative Western blotting to confirm protein depletion:

    • Load equal amounts of total protein from wild-type and knockout/knockdown samples

    • Include internal loading controls (e.g., actin, GAPDH)

    • Implement densitometry analysis for quantitative assessment

  • Use immunofluorescence microscopy to confirm loss of YNR040W signal in manipulated cells

  • Consider flow cytometry with permeabilized cells for high-throughput validation

• Rescue Experiments:

  • Design complementation constructs expressing wild-type YNR040W

  • Create point mutants in functional domains to assess structure-function relationships

  • Validate rescue at both protein level (using antibody) and functional level

• Phenotypic Analysis Pipeline:

  • Measure mitochondrial parameters including:

    • Oxygen consumption rates

    • Membrane potential using fluorescent probes

    • mtDNA copy number

    • Mitoribosome assembly using sucrose gradient fractionation

  • Assess cellular growth in fermentable versus non-fermentable carbon sources

  • Analyze mitochondrial morphology using electron microscopy

• Controls and Validation Stringency:

  • Include isogenic wild-type controls in all experiments

  • Implement multiple independent knockout/knockdown clones

  • Use complementary techniques beyond antibody detection (e.g., RT-qPCR, RNA-seq)

  • Consider targeting YNR040W homologs in other model organisms for evolutionary insights

This comprehensive approach ensures rigorous validation of genetic manipulation experiments and reliable interpretation of functional data.

What are the emerging techniques for studying YNR040W interactions with the mitoribosomal complex?

Several cutting-edge techniques can provide deeper insights into YNR040W's role in mitoribosomal function:

• Cryo-Electron Microscopy:

  • Implement single-particle cryo-EM to determine the position of YNR040W within the mitoribosomal structure

  • Use YNR040W antibody with gold nanoparticle labeling for precise localization

  • Perform structural comparisons between wild-type mitoribosomes and those depleted of YNR040W

  • Combine with computational modeling to predict functional interfaces

• Proximity-based Proteomics:

  • Implement BioID or APEX2 proximity labeling with YNR040W as the bait protein

  • Map the proximal protein environment within the mitoribosome

  • Compare proximity profiles under different metabolic conditions

  • Identify dynamic interaction partners during mitoribosome assembly and function

• In situ Structural Analysis:

  • Apply correlative light and electron microscopy (CLEM) using YNR040W antibody

  • Implement super-resolution microscopy techniques (STORM, PALM) for nanometer-scale localization

  • Use expansion microscopy to physically enlarge specimens for improved resolution

  • Combine with electron tomography for 3D structural context

• Real-time Interaction Monitoring:

  • Develop FRET-based biosensors to monitor YNR040W interactions in living cells

  • Implement split fluorescent protein complementation assays for binary interaction validation

  • Use fluorescence correlation spectroscopy (FCS) to measure binding kinetics in vitro and in vivo

  • Apply single-molecule tracking to observe dynamic behavior of YNR040W during ribosome assembly

• Functional Assays for Mitoribosomal Activity:

  • Implement in vitro translation systems with purified mitoribosomes containing or lacking YNR040W

  • Measure translation rates of mitochondrially-encoded proteins using radioactive amino acid incorporation

  • Assess ribosomal subunit joining efficiency in the presence and absence of YNR040W

  • Develop high-throughput assays based on luciferase reporters for mitochondrial translation

• Integration with Structural Biology Data:

  • Map YNR040W position relative to functional sites like the peptidyl transferase center

  • Identify potential interaction with mitochondrial mRNAs, tRNAs, or translation factors

  • Predict functional roles based on structural features and evolutionary conservation

  • Design targeted mutagenesis experiments based on structural insights

These emerging techniques provide multidimensional insights into YNR040W function within the mitoribosomal complex and enable researchers to develop mechanistic models of its role in mitochondrial translation.

What are the recommended best practices for validating and reporting YNR040W antibody-based research findings?

To ensure reproducibility and reliability in YNR040W antibody research:

• Comprehensive Antibody Validation:

  • Perform specificity testing using knockout/knockdown controls

  • Validate across multiple applications (WB, IP, IF) with appropriate controls

  • Report detailed antibody information including:

    • Catalog number and lot number

    • Host species and clonality

    • Immunogen sequence

    • Working dilutions for each application

  • Consider using orthogonal detection methods to confirm key findings

• Experimental Design Considerations:

  • Implement biological replicates (minimum n=3) and technical replicates

  • Include appropriate positive and negative controls in all experiments

  • Use quantitative approaches with appropriate statistical analysis

  • Blind analysis where feasible to reduce confirmation bias

• Data Reporting Standards:

  • Provide full, unedited Western blot images with molecular weight markers

  • Include all controls in published images

  • Report quantification methods and raw data when possible

  • Disclose image acquisition and processing parameters

• Method Documentation:

  • Provide detailed protocols including buffer compositions

  • Report incubation times, temperatures, and washing conditions

  • Document any optimization steps that were critical for success

  • Consider publishing detailed protocols in repositories like protocols.io

These practices ensure that YNR040W antibody-based research is robust, reproducible, and builds a reliable foundation for future studies.

What future research directions are anticipated for YNR040W antibody applications in mitochondrial biology?

As research on mitochondrial function continues to evolve, several promising directions for YNR040W antibody applications emerge:

• Integration with Systems Biology Approaches:

  • Combine YNR040W antibody data with multi-omics datasets to build comprehensive models of mitochondrial function

  • Implement network analysis to identify YNR040W's position in global regulatory networks

  • Develop predictive models of mitochondrial biogenesis incorporating YNR040W as a key component

• Translational Research Applications:

  • Explore relevance to human mitochondrial diseases by identifying human homologs

  • Develop YNR040W-based assays for mitochondrial dysfunction in disease models

  • Investigate potential as a biomarker for specific mitochondrial pathologies

• Evolutionary Biology Perspectives:

  • Compare YNR040W structure and function across diverse eukaryotic lineages

  • Investigate how YNR040W contributes to species-specific adaptations in mitochondrial function

  • Trace evolutionary history of the mitoribosomal complex with YNR040W as a focal point

• Technological Innovations:

  • Develop new antibody formats (single-domain antibodies, nanobodies) for improved accessibility to complex structures

  • Implement multiplexed imaging approaches for simultaneous visualization of multiple mitochondrial components

  • Create antibody-based biosensors for real-time monitoring of YNR040W dynamics

• Therapeutic Implications:

  • Explore YNR040W homologs in pathogens as potential drug targets

  • Investigate whether modulation of YNR040W-like proteins could restore mitochondrial function in disease states

  • Develop screening platforms to identify compounds that affect mitoribosomal assembly

These future directions highlight the continuing importance of YNR040W antibody research in advancing our understanding of fundamental mitochondrial biology and its applications in biomedicine.